Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)

American Journal of Cardiology

Volumn 111, Issue 4, 2013, Pages 582-587

  Mentz, Robert J ^a   Wojdyla, Daniel ^b   Fiuzat, Mona ^a,b   Chiswell, Karen ^b   Fonarow, Gregg C ^c   O'Connor, Christopher M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; LABETALOL; METOPROLOL; NADOLOL; NEBIVOLOL; PINDOLOL; PROPRANOLOL; TIMOLOL;

ADULT; AGED; ARTICLE; CARDIOSELECTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG USE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC DYSFUNCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84873305611     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.041     Document Type: Article

References (30)

1. N.M. Hawkins, M.C. Petrie, P.S. Jhund, G.W. Chalmers, F.G. Dunn, and J.J. McMurray Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail 11 2009 130 139
2. N.M. Hawkins, P.S. Jhund, C.R. Simpson, M.C. Petrie, M.R. Macdonald, F.G. Dunn, K. Macintyre, and J.J. McMurray Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland Eur J Heart Fail 12 2010 17 24
3. A. Macchia, S. Monte, M. Romero, A. D'Ettorre, and G. Tognoni The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure Eur J Heart Fail 9 2007 942 948
4. R.J. Mentz, M. Fiuzat, D.M. Wojdyla, K. Chiswell, M. Gheorghiade, G.C. Fonarow, and C.M. O'Connor Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF Eur J Heart Fail 14 2012 395 403
5. R.J. Mentz, P.H. Schmidt, M.J. Kwasny, A.P. Ambrosy, C.M. O'Connor, M.A. Konstam, F. Zannad, A.P. Maggioni, K. Swedberg, and M. Gheorghiade The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial J Card Fail 18 2012 515 523
6. N.M. Hawkins, M.C. Petrie, M.R. Macdonald, P.S. Jhund, L.M. Fabbri, J. Wikstrand, and J.J. McMurray Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonists J Am Coll Cardiol 57 2011 2127 2138
7. H.D. Dungen, S. Apostolovic, S. Inkrot, E. Tahirovic, A. Topper, F. Mehrhof, C. Prettin, B. Putnikovic, A.N. Neskovic, M. Krotin, D. Sakac, M. Lainscak, F. Edelmann, R. Wachter, T. Rau, T. Eschenhagen, W. Doehner, S.D. Anker, F. Waagstein, C. Herrmann-Lingen, G. Gelbrich, and R. Dietz Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial Eur J Heart Fail 13 2011 670 680
8. R.J. Mentz, M. Fiuzat, M. Kraft, J. Lindenfeld, and C.M. O'Connor Bronchodilators in heart failure patients with COPD: is it time for a clinical trial? J Card Fail 18 2012 413 422
9. A. Jabbour, P.S. Macdonald, A.M. Keogh, E. Kotlyar, S. Mellemkjaer, C.F. Coleman, M. Elsik, H. Krum, and C.S. Hayward Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial J Am Coll Cardiol 55 2010 1780 1787
10. M. Lainscak, M. Podbregar, D. Kovacic, J. Rozman, and S. von Haehling Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial Respir Med 105 suppl 2011 S44 S49
11. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.A. Gattis, M. Gheorghiade, B. Greenberg, C.M. O'Connor, C.W. Yancy, and J. Young Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51
12. C.M. O'Connor, W.T. Abraham, N.M. Albert, R. Clare, W. Gattis Stough, M. Gheorghiade, B.H. Greenberg, C.W. Yancy, J.B. Young, and G.C. Fonarow Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
13. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, K. Pieper, J.L. Sun, C. Yancy, and J.B. Young Association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70
14. M.G. Matera, E. Martuscelli, and M. Cazzola Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure Pulm Pharmacol Ther 23 2010 1 8
15. S. Salpeter, T. Ormiston, and E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 2005 CD003566
16. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C. Yancy, and J.B. Young Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Am Heart J 153 2007 82.e1 82.e11
17. M.R. Bristow, R. Ginsburg, V. Umans, M. Fowler, W. Minobe, R. Rasmussen, P. Zera, R. Menlove, P. Shah, S. Jamieson, and E.B. Stinson Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ Res 59 1986 297 309
18. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, and A. Skene Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
19. E.R. Azevedo, T. Kubo, S. Mak, A. Al-Hesayen, A. Schofield, R. Allan, S. Kelly, G.E. Newton, J.S. Floras, and J.D. Parker Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity Circulation 104 2001 2194 2199
20. M. Johnson The beta-adrenoceptor Am J Respir Crit Care Med 158 1998 S146 S153
21. Z. Callaerts-Vegh, K.L. Evans, N. Dudekula, D. Cuba, B.J. Knoll, P.F. Callaerts, H. Giles, F.R. Shardonofsky, and R.A. Bond Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma Proc Natl Acad Sci U S A 101 2004 4948 4953
22. R. Lin, H. Peng, L.P. Nguyen, N.B. Dudekula, F. Shardonofsky, B.J. Knoll, S. Parra, and R.A. Bond Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of "beta-blockers" in a murine asthma model Pulm Pharmacol Ther 21 2008 115 124
23. L.P. Nguyen, O. Omoluabi, S. Parra, J.M. Frieske, C. Clement, Z. Ammar-Aouchiche, S.B. Ho, C. Ehre, M. Kesimer, B.J. Knoll, M.J. Tuvim, B.F. Dickey, and R.A. Bond Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model Am J Respir Cell Mol Biol 38 2008 256 262
24. F.H. Rutten, N.P. Zuithoff, E. Hak, D.E. Grobbee, and A.W. Hoes Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease Arch Intern Med 170 2010 880 887
25. P.M. Short, S.I. Lipworth, D.H. Elder, S. Schembri, and B.J. Lipworth Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study BMJ 342 2011 d2549
26. M.T. Dransfield, S.M. Rowe, J.E. Johnson, W.C. Bailey, and L.B. Gerald Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD Thorax 63 2008 301 305
27. M. Fiuzat, D. Wojdyla, D. Kitzman, J. Fleg, S.J. Keteyian, W.E. Kraus, I.L. Pina, D. Whellan, and C.M. O'Connor Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial J Am Coll Cardiol 60 2012 208 215
28. R.W. Light, and R.B. George Serial pulmonary function in patients with acute heart failure Arch Intern Med 143 1983 429 433
29. C.C. Naum, F.C. Sciurba, and R.M. Rogers Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation Am Rev Respir Dis 145 1992 1334 1338
30. J.G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, J.C. Aguilar, R. Dietz, A. Gavazzi, R. Hobbs, J. Korewicki, H.C. Madeira, V.S. Moiseyev, I. Preda, W.H. van Gilst, J. Widimsky, N. Freemantle, J. Eastaugh, and J. Mason The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463